493 related articles for article (PubMed ID: 37564215)
1. Broadening horizons: the multifaceted functions of ferroptosis in kidney diseases.
Feng Q; Yang Y; Ren K; Qiao Y; Sun Z; Pan S; Liu F; Liu Y; Huo J; Liu D; Liu Z
Int J Biol Sci; 2023; 19(12):3726-3743. PubMed ID: 37564215
[TBL] [Abstract][Full Text] [Related]
2. Ferroptosis and Acute Kidney Injury (AKI): Molecular Mechanisms and Therapeutic Potentials.
Feng Q; Yu X; Qiao Y; Pan S; Wang R; Zheng B; Wang H; Ren KD; Liu H; Yang Y
Front Pharmacol; 2022; 13():858676. PubMed ID: 35517803
[TBL] [Abstract][Full Text] [Related]
3. Emerging Role of Ferroptosis in Diabetic Kidney Disease: Molecular Mechanisms and Therapeutic Opportunities.
Wang H; Liu D; Zheng B; Yang Y; Qiao Y; Li S; Pan S; Liu Y; Feng Q; Liu Z
Int J Biol Sci; 2023; 19(9):2678-2694. PubMed ID: 37324941
[TBL] [Abstract][Full Text] [Related]
4. A Deep Insight into Ferroptosis in Renal Disease: Facts and Perspectives.
Han Z; Luo Y; Chen H; Zhang G; You L; Zhang M; Lin Y; Yuan L; Zhou S
Kidney Dis (Basel); 2024 Jun; 10(3):224-236. PubMed ID: 38835406
[TBL] [Abstract][Full Text] [Related]
5. Targeting ferroptosis in acute kidney injury.
Ni L; Yuan C; Wu X
Cell Death Dis; 2022 Feb; 13(2):182. PubMed ID: 35210424
[TBL] [Abstract][Full Text] [Related]
6. The role of ferroptosis in the development of acute and chronic kidney diseases.
Zhou Y; Zhang J; Guan Q; Tao X; Wang J; Li W
J Cell Physiol; 2022 Dec; 237(12):4412-4427. PubMed ID: 36260516
[TBL] [Abstract][Full Text] [Related]
7. Abnormal Iron and Lipid Metabolism Mediated Ferroptosis in Kidney Diseases and Its Therapeutic Potential.
Zhang X; Li X
Metabolites; 2022 Jan; 12(1):. PubMed ID: 35050181
[TBL] [Abstract][Full Text] [Related]
8. Emerging Role of Ferroptosis in Acute Kidney Injury.
Hu Z; Zhang H; Yang SK; Wu X; He D; Cao K; Zhang W
Oxid Med Cell Longev; 2019; 2019():8010614. PubMed ID: 31781351
[TBL] [Abstract][Full Text] [Related]
9. Novel Insight into Ferroptosis in Kidney Diseases.
Yang L; Liu Y; Zhou S; Feng Q; Lu Y; Liu D; Liu Z
Am J Nephrol; 2023; 54(5-6):184-199. PubMed ID: 37231767
[TBL] [Abstract][Full Text] [Related]
10. Research progress on ferroptosis in diabetic kidney disease.
Wu Y; Chen Y
Front Endocrinol (Lausanne); 2022; 13():945976. PubMed ID: 36246888
[TBL] [Abstract][Full Text] [Related]
11. Emerging significance and therapeutic targets of ferroptosis: a potential avenue for human kidney diseases.
Li J; Zheng S; Fan Y; Tan K
Cell Death Dis; 2023 Sep; 14(9):628. PubMed ID: 37739961
[TBL] [Abstract][Full Text] [Related]
12. Ferroptosis: A Potential Therapeutic Target in Acute Kidney Injury.
Hosohata K; Harnsirikarn T; Chokesuwattanaskul S
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743026
[TBL] [Abstract][Full Text] [Related]
13. Ferroptosis in renal fibrosis: a mini-review.
Yang SQ; Zhao X; Zhang J; Liao DY; Wang YH; Wang YG
J Drug Target; 2024 May; ():1-9. PubMed ID: 38721679
[TBL] [Abstract][Full Text] [Related]
14. Ferroptosis: an important player in the inflammatory response in diabetic nephropathy.
Li J; Li L; Zhang Z; Chen P; Shu H; Yang C; Chu Y; Liu J
Front Immunol; 2023; 14():1294317. PubMed ID: 38111578
[TBL] [Abstract][Full Text] [Related]
15. Ferroptosis in acute kidney injury following crush syndrome: A novel target for treatment.
Qiao O; Wang X; Wang Y; Li N; Gong Y
J Adv Res; 2023 Dec; 54():211-222. PubMed ID: 36702249
[TBL] [Abstract][Full Text] [Related]
16. Copper homeostasis in chronic kidney disease and its crosstalk with ferroptosis.
Jiayi H; Ziyuan T; Tianhua X; Mingyu Z; Yutong M; Jingyu W; Hongli Z; Li S
Pharmacol Res; 2024 Apr; 202():107139. PubMed ID: 38484857
[TBL] [Abstract][Full Text] [Related]
17. Ferroptosis: A new mechanism of traditional Chinese medicine compounds for treating acute kidney injury.
Shi Y; Shi X; Zhao M; Chang M; Ma S; Zhang Y
Biomed Pharmacother; 2023 Jul; 163():114849. PubMed ID: 37172334
[TBL] [Abstract][Full Text] [Related]
18. Ferroptosis: past, present and future.
Li J; Cao F; Yin HL; Huang ZJ; Lin ZT; Mao N; Sun B; Wang G
Cell Death Dis; 2020 Feb; 11(2):88. PubMed ID: 32015325
[TBL] [Abstract][Full Text] [Related]
19. Novel 3-hydroxypyridin-4(1H)-One derivatives as ferroptosis inhibitors with iron-chelating and reactive oxygen species scavenging activities and therapeutic effect in cisplatin-induced cytotoxicity.
Zhang C; Lu Y; Zhang J; Zang A; Ren J; Zheng Z; Fan M; Xie Y
Eur J Med Chem; 2024 Jan; 263():115945. PubMed ID: 37976709
[TBL] [Abstract][Full Text] [Related]
20. Empagliflozin attenuates the renal tubular ferroptosis in diabetic kidney disease through AMPK/NRF2 pathway.
Lu Q; Yang L; Xiao JJ; Liu Q; Ni L; Hu JW; Yu H; Wu X; Zhang BF
Free Radic Biol Med; 2023 Feb; 195():89-102. PubMed ID: 36581059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]